Tabid, Dan Aiza .
HRN: 20-46-76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/29/2023
CEFUROXIME 750MG (VIAL)
08/29/2023
09/04/2023
IV
350mg
Q8
PCAP C
Waiting Final Action